CHASE PODIATRY LTD
Executive Summary
Chase Podiatry Ltd exhibits a stable financial position with improving net assets and strong cash balances, supporting a low risk rating. However, the significant rise in current liabilities and limited disclosure of profitability warrant further investigation. Overall, the company appears compliant and operationally sound, but investors should seek additional financial detail to fully assess sustainability.
View Full Analysis Report →- Legal registered address
- 5 Boyden Close Penkridge United Kingdom ST19 5TG Copied!
Latest financial results as of 11 November 2025- Cash in bank
- £53.16k
- Current assets
- £59.17k
- Current creditors
- £54.84k
- Shareholders funds
- £12.73k
View full financial accounts- Cash in bank
- £53.16k
- Current assets
- £59.17k
- Current creditors
- £54.84k
- Shareholders funds
- £12.73k
- Company number
- 13710281 Copied!
Accounts
Latest annual accounts were to 31 May 2024
Next annual accounts are due by 28 February 2026
Company financial year end is on 31 May 2026
Confirmation statement
Latest confirmation statement statement dated 30 September 2025
Next statement due by 14 October 2026
Nature of business (SIC)
86220 - Specialists medical practice activities
Latest company documents
| Date | Description |
|---|---|
| 30/09/2530 September 2025 New | Confirmation statement made on 2025-09-30 with no updates |
| 20/12/2420 December 2024 | Total exemption full accounts made up to 2024-05-31 |
| 14/10/2414 October 2024 | Confirmation statement made on 2024-10-14 with updates |
| 03/06/243 June 2024 | Change of details for Mrs Susan Elizabeth Powell as a person with significant control on 2024-06-03 |
| 31/05/2431 May 2024 | Annual accounts for year ending 31 May 2024 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company